Calcific Aortic Valve Disease: a Developmental Biology Perspective
- PMID: 29520694
- PMCID: PMC5842494
- DOI: 10.1007/s11886-018-0968-9
Calcific Aortic Valve Disease: a Developmental Biology Perspective
Abstract
Purpose of review: This review aims to highlight the past and more current literature related to the multifaceted pathogenic programs that contribute to calcific aortic valve disease (CAVD) with a focus on the contribution of developmental programs.
Recent findings: Calcification of the aortic valve is an active process characterized by calcific nodule formation on the aortic surface leading to a less supple and more stiffened cusp, thereby limiting movement and causing clinical stenosis. The mechanisms underlying these pathogenic changes are largely unknown, but emerging studies have suggested that signaling pathways common to valvulogenesis and bone development play significant roles and include Transforming Growth Factor-β (TGF-β), bone morphogenetic protein (BMP), Wnt, Notch, and Sox9. This comprehensive review of the literature highlights the complex nature of CAVD but concurrently identifies key regulators that can be targeted in the development of mechanistic-based therapies beyond surgical intervention to improve patient outcome.
Keywords: Calcification; Cell signaling; Extracellular matrix; Heart valve; Valvulogenesis.
Conflict of interest statement
Conflict of Interest
Punashi Dutta and Joy Lincoln have no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Figures
Similar articles
-
Molecular biology of calcific aortic valve disease: towards new pharmacological therapies.Expert Rev Cardiovasc Ther. 2014 Jul;12(7):851-62. doi: 10.1586/14779072.2014.923756. Epub 2014 May 24. Expert Rev Cardiovasc Ther. 2014. PMID: 24857537 Review.
-
Bone Morphogenetic Protein Signaling Is Required for Aortic Valve Calcification.Arterioscler Thromb Vasc Biol. 2016 Jul;36(7):1398-405. doi: 10.1161/ATVBAHA.116.307526. Epub 2016 May 19. Arterioscler Thromb Vasc Biol. 2016. PMID: 27199449 Free PMC article.
-
Cadherin-11 Overexpression Induces Extracellular Matrix Remodeling and Calcification in Mature Aortic Valves.Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1627-37. doi: 10.1161/ATVBAHA.116.307812. Epub 2016 Jun 16. Arterioscler Thromb Vasc Biol. 2016. PMID: 27312222 Free PMC article.
-
AntagomiR-29b inhibits vascular and valvular calcification and improves heart function in rats.J Cell Mol Med. 2020 Oct;24(19):11546-11557. doi: 10.1111/jcmm.15770. Epub 2020 Aug 26. J Cell Mol Med. 2020. PMID: 32845082 Free PMC article.
-
The progression of calcific aortic valve disease through injury, cell dysfunction, and disruptive biologic and physical force feedback loops.Cardiovasc Pathol. 2013 Jan-Feb;22(1):1-8. doi: 10.1016/j.carpath.2012.06.005. Epub 2012 Jul 12. Cardiovasc Pathol. 2013. PMID: 22795219 Review.
Cited by
-
CircRNA/lncRNA-miRNA-mRNA network and gene landscape in calcific aortic valve disease.BMC Genomics. 2023 Jul 25;24(1):419. doi: 10.1186/s12864-023-09441-y. BMC Genomics. 2023. PMID: 37491214 Free PMC article.
-
Bioinformatics-Based Identification of CircRNA-MicroRNA-mRNA Network for Calcific Aortic Valve Disease.Genet Res (Camb). 2023 May 17;2023:8194338. doi: 10.1155/2023/8194338. eCollection 2023. Genet Res (Camb). 2023. PMID: 37234568 Free PMC article.
-
Dantrolene inhibits lysophosphatidylcholine-induced valve interstitial cell calcific nodule formation via blockade of the ryanodine receptor.Front Cardiovasc Med. 2023 Mar 30;10:1112965. doi: 10.3389/fcvm.2023.1112965. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37063962 Free PMC article.
-
Exploration and validation of the influence of angiogenesis-related factors in aortic valve calcification.Front Cardiovasc Med. 2023 Feb 7;10:1061077. doi: 10.3389/fcvm.2023.1061077. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36824454 Free PMC article.
-
Sclerostin ablation prevents aortic valve stenosis in mice.Am J Physiol Heart Circ Physiol. 2022 Nov 1;323(5):H1037-H1047. doi: 10.1152/ajpheart.00355.2022. Epub 2022 Oct 14. Am J Physiol Heart Circ Physiol. 2022. PMID: 36240434 Free PMC article.
References
-
- Nasir K, Katz R, Takasu J, Shavelle DM, Detrano R, Lima JA, et al. Ethnic differences between extra-coronary measures on cardiac computed tomography: multi-ethnic study of atherosclerosis (MESA) Atherosclerosis. 2008;198(1):104–114. - PubMed
-
- Otto CM, Burwash IG, Legget ME, Munt BI, Fujioka M, Healy NL, et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation. 1997;95(9):2262–2270. - PubMed
-
- Otto CM, Prendergast B. Aortic-valve stenosis—from patients at risk to severe valve obstruction. New Engl J Med. 2014;371(8):744–756. - PubMed
-
- Mohler ER., 3rd Are atherosclerotic processes involved in aortic-valve calcification? Lancet. 2000;356(9229):524–525. - PubMed
-
- Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29(3):630–634. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
